Research into human embryo stem cells has been authorised in Germany since 2002 (see Germany and embryo stem cells; Germany: “yes” to the importation of embryo stem cells; Germany: importation of embryo stem cells extended), “without any restriction from legislation to protect embryos”  passed in 1990. The seventh edition of the Government report on “applying legislation to stem cells” has “progressed” in this area both for human embryo stem cells and induced pluripotent stem cells (iPS). According to the report, work on iPS cells “is gaining significance” and “considerable progress has been made in an attempt to understand the causes and extent of genetic and epigenetic changes and in the generation and safe propagation of human iPS cells”.
With regard to human embryo stem cells, 105 research authorisations have been granted since 2002, including 17 in 2014-2015.
 “This law regulates the limits of medicine, reproduction and genetic engineering in Germany. It essentially criminalises the production of human embryos for commercial purposes or research. Similarly, the gender of unborn babies cannot be determined and access to a surrogate mother is not permitted. Egg donation is prohibited and sperm donation is authorised only if the identity of the donor is known”.